FMAGX
Price
$15.06
Change
-$0.04 (-0.26%)
Updated
Sep 20 closing price
GAFFX
Price
$77.04
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

FMAGX vs GAFFX

Header iconFMAGX vs GAFFX Comparison
Open Charts FMAGX vs GAFFXBanner chart's image
Fidelity Magellan
Price$15.06
Change-$0.04 (-0.26%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer F3
Price$77.04
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FMAGX vs GAFFX Comparison Chart
Loading...
VS
FMAGX vs. GAFFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAGX is a Buy and GAFFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 290B vs. FMAGX (35.6B). GAFFX pays higher dividends than FMAGX: GAFFX (0.75) vs FMAGX (0.33). FMAGX was incepted earlier than GAFFX: FMAGX (61 years) vs GAFFX (8 years). FMAGX is a more actively managed with annual turnover of: 86.00 vs. GAFFX (31.00). FMAGX has a lower initial minimum investment than GAFFX: FMAGX (0) vs GAFFX (1000000). FMAGX annual gain was more profitable for investors over the last year : 37.04 vs. GAFFX (30.65). GAFFX return over 5 years is better than : 55.06 vs. FMAGX (39.07).
FMAGXGAFFXFMAGX / GAFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence61 years8 years-
Gain YTD22.40021.995102%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets35.6B290B12%
Annual Yield % from dividends0.330.7544%
Returns for 1 year37.0430.65121%
Returns for 3 years4.131.28324%
Returns for 5 years39.0755.0671%
Returns for 10 years60.64N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTNP5.660.10
+1.80%
Titan Pharmaceuticals
INCR1.870.01
+0.54%
Intercure Ltd
Z67.09-0.75
-1.11%
Zillow Group
BATRA43.56-0.64
-1.45%
Atlanta Braves Holdings
ALLO2.81-0.11
-3.61%
Allogene Therapeutics